Please use this identifier to cite or link to this item:
Title: Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry
Authors: Pasikanti, K.K.
Esuvaranathan, K.
Hong, Y.
Ho, P.C. 
Mahendran, R. 
Raman Nee Mani, L.
Chiong, E.
Chan, E.C.Y. 
Keywords: bladder cancer
two dimensional gas chromatography
Issue Date: 6-Sep-2013
Citation: Pasikanti, K.K., Esuvaranathan, K., Hong, Y., Ho, P.C., Mahendran, R., Raman Nee Mani, L., Chiong, E., Chan, E.C.Y. (2013-09-06). Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry. Journal of Proteome Research 12 (9) : 3865-3873. ScholarBank@NUS Repository.
Abstract: Cystoscopy is the gold standard clinical diagnosis of human bladder cancer (BC). As cystoscopy is expensive and invasive, it compromises patients' compliance toward surveillance screening and challenges the detection of recurrent BC. Therefore, the development of a noninvasive method for the diagnosis and surveillance of BC and the elucidation of BC progression become pertinent. In this study, urine samples from 38 BC patients and 61 non-BC controls were subjected to urinary metabotyping using two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC-TOFMS). Subsequent to data preprocessing and chemometric analysis, the orthogonal partial least-squares discriminant analysis (OPLS-DA, R2X = 0.278, R 2Y = 0.904 and Q2Y (cumulative) = 0.398) model was validated using permutation tests and receiver operating characteristic (ROC) analysis. Marker metabolites were further screened from the OPLS-DA model using statistical tests. GC×GC-TOFMS urinary metabotyping demonstrated 100% specificity and 71% sensitivity in detecting BC, while 100% specificity and 46% sensitivity were observed via cytology. In addition, the model revealed 46 metabolites that characterize human BC. Among the perturbed metabolic pathways, our clinical finding on the alteration of the tryptophan-quinolinic metabolic axis in BC suggested the potential roles of kynurenine in the malignancy and therapy of BC. In conclusion, global urinary metabotyping holds potential for the noninvasive diagnosis and surveillance of BC in clinics. In addition, perturbed metabolic pathways gleaned from urinary metabotyping shed new and established insights on the biology of human BC. © 2013 American Chemical Society.
Source Title: Journal of Proteome Research
ISSN: 15353893
DOI: 10.1021/pr4000448
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Oct 19, 2018


checked on Oct 3, 2018

Page view(s)

checked on Sep 14, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.